Records 1 - 30
| Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations.
ESMO open 2022 Dec 7 (6): 100742.
Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J
| Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments.
Oncology letters 2022 Oct 24 (4): 362.
Zhou Lin, Li Huiwu, Yang Shuh
| ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer.
Thoracic cancer 2022 Oct .
de Oliveira Cavagna Rodrigo, Zaniolo Beatriz Garbe, de Paula Flávia Escremim, Berardinelli Gustavo Noriz, Santana Iara, da Silva Eduardo Caetano Albino, Dias Josiane Mourão, Jacinto Alexandre Arthur, da Nóbrega Oliveira Rachid Eduardo Noleto, de Marchi Pedro, Leal Letícia Ferro, Reis Rui Manu
| Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort.
Lung cancer (Amsterdam, Netherlands) 2022 Oct 174 27-35.
Bubendorf Lukas, Zoche Martin, Dafni Urania, Rüschoff Jan Hendrik, Prince Spasenija Savic, Marti Nesa, Stavrou Androniki, Kammler Roswitha, Finn Stephen P, Moch Holger, Peters Solange, Stahel Rolf
| Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity-matched analysis in a cohort of 147 recurrences.
Thoracic cancer 2022 Sep .
Xu Fei, Chen Heng-Chi, Xu Haiyan, Li Junling, Hao Xuezhi, Xing Puyuan, Ying Jianming, Wang Y
| Chronic rhinosinusitis with nasal polyps does not harbor KRAS, BRAF, and EGFR mutations.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2022 Sep .
Vieira Tamara da Silva, Guimarães Letícia Martins, Diniz Marina Gonçalves, Gomes-Fernandes Bianca, Anselmo-Lima Wilma Terezinha, Tamashiro Edwin, Bastos-Rodrigues Luciana, De Marco Luiz, Gomez Ricardo Santiago, Valera Fabiana Cardoso Pereira, Gomes Carolina Cavalie
| Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations.
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2022 Sep 25 (9): 651-657.
Zhang Guowei, Cheng Ruirui, Niu Yuanyuan, Wang Huijuan, Yan Xiangtao, Zhang Mina, Zhang Xiaojuan, Yang Jinpo, Wei Chunhua, Ma Zhiyo
| Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing.
Journal of pathology and translational medicine 2022 Sep 56 (5): 249-259.
Lee Jeonghyo, Han Yeon Bi, Kwon Hyun Jung, Lee Song Kook, Kim Hyojin, Chung Jin-Hae
| Pre-radiotherapy systemic immune inflammation index associated with overall survival in patients with advanced EGFR mutant non-small cell lung cancer receiving thoracic radiotherapy.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2022 Sep .
Chen Dujuan, Qin Hongyue, Deng Guangchuan, Wang Qi, Wang Haiyong, Liu Xij
| Sputum cell-free DNA for detection of alterations of multiple driver genes in lung adenocarcinoma.
Cancer cytopathology 2022 Sep .
Wang Zheng, Li Lin, Wang Yifei, Li Xiaoguang, Xu Yan, Wang Mengzhao, Liang Li, Wu Xiaonan, Tang Min, Li Yuanming, He Shurong, Du Jun, He Lei, Sun Mingjun, Yang Li, Di Jing, Gai Fei, Liu Dong
| Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients.
The Journal of thoracic and cardiovascular surgery 2022 Aug .
Hashimoto Kohei, Ariyasu Ryo, Ichinose Junji, Matsuura Yosuke, Nakao Masayuki, Amino Yoshiaki, Uchibori Ken, Kitazono Satoru, Yanagitani Noriko, Okumura Sakae, Nishio Makoto, Mun Mingy
| Retrospective analysis of independent predictors of progression-free survival in patients with EGFR mutation-positive advanced non-small cell lung cancer receiving first-line osimertinib.
Thoracic cancer 2022 Aug .
Teranishi Shuhei, Sugimoto Chihiro, Nagaoka Satoshi, Nagayama Hirokazu, Segawa Wataru, Miyasaka Atsushi, Hiro Shuntaro, Kajita Yukihito, Maeda Chihiro, Kobayashi Nobuaki, Yamamoto Masaki, Kudo Makoto, Kaneko Takes
| The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
BMC cancer 2022 Aug 22 (1): 875.
Ito Hiroyuki, Date Hiroshi, Shintani Yasushi, Miyaoka Etsuo, Nakanishi Ryoichi, Kadokura Mitsutaka, Endo Shunsuke, Chida Masayuki, Yoshino Ichiro, Suzuki Hidemi,
| Use of thyroid transcription factor 1 and napsin A to predict local failure and survival after Gamma Knife radiosurgery in patients with brain metastases from lung adenocarcinoma.
Journal of neurosurgery 2022 Aug 1-11.
Roh Haewon, Lee Sung Yong, Lee Jinhwan, Hwang Soon-Young, Kim Jong Hy
| Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma.
Journal of cancer research and clinical oncology 2022 Jul .
Li Peng, Che Shuyu, Qi Yingxue, Luo Ningning, Lin Qiuju, Zhu Xiaofeng, Xuan Yunpeng, Li Mengmeng, Li Jinlong, Ge Minghui, Sun Tingting, Qi Chuang, Wang Yongj
| Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program.
Seminars in oncology 2022 Jul .
Jalal Shadia I, Guo Aixia, Ahmed Sara, Kelley Michael
| Association between squamous cell carcinoma antigen level and EGFR mutation status in Chinese lung adenocarcinoma patients.
Journal of clinical laboratory analysis 2022 Jul e24613.
Zhang Shuying, Gao Jianxiong, Niu Rong, Ye Jiru, Ma Jinhong, Jiang Lijuan, Shao Xiaon
| CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma.
Medicine 2022 Jul 101 (30): e29796.
Zhang Sen, Li Na, Yang Yonghua, Li Yan, Lin Chenshi, Fu Guoquan, Cai J
| Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma.
Lung cancer (Amsterdam, Netherlands) 2022 Jul 170 176-184.
Ahn Bokyung, Yoon Shinkyo, Kim Deokhoon, Chun Sung-Min, Lee Goeun, Kim Hyeong-Ryul, Jin Jang Se, Sang Hwang H
| Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles.
Clinical lung cancer 2022 Jul .
Hsu Robert, Herrmann Amanda, Gaur Kush, Xia Bing, Nieva Jorge
| MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study.
Journal of cancer research and clinical oncology 2022 Jul .
Wang Na, Zhu Yili, Wu Ying, Huang Bo, Wu Junhua, Zhang Ruiguang, Fan Jun, Nie X
| Prognostic factors in completely resected lymph-node-negative pulmonary adenocarcinoma.
Translational cancer research 2022 Jul 11 (7): 2238-2248.
Pakvisal Nussara, Chantranuwat Poonchavist, Vinayanuwattikun Chanida, Sitthideatphaiboon Piyada, Teerapakpinyo Chinachote, Shuangshoti Shanop, Benjacholamas Vichai, Pornpattanarak Nopporn, Sriuranpong Viro
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib.
BMC medical genomics 2022 Jun 15 (1): 141.
Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X
| Molecular profile of non-small cell lung cancer in reunion Island.
Respiratory medicine and research 2022 Jun 82 100939.
Moreau Diane, Huchot Eric, Foch Emilie, Allou Nathalie, Caumont Charline, Merlio Jean Philippe, Andre Mich
| Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinoma.
Frontiers in oncology 2022 12 985284.
Jiang Meilin, Yang Pei, Li Jing, Peng Wenying, Pu Xingxiang, Chen Bolin, Li Jia, Wang Jingyi, Wu L
| Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study [Retraction].
OncoTargets and therapy 2022 10 15 1271-1272.
Authors are not available
| Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer.
Emergency medicine international 2022 2022 6333282.
Kong Wencui, Yu Zongyang, Wang Wenwu, Yang Jingrong, Wang Jingfang, Zhao Zhongqu
| Genomic landscape of lung adenocarcinomas in different races.
Frontiers in oncology 2022 12 946625.
Shi Huashan, Seegobin Karan, Heng Fei, Zhou Kexun, Chen Ruqin, Qin Hong, Manochakian Rami, Zhao Yujie, Lou Yany
| Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients.
International journal of environmental research and public health 2022 08 19 (16): .
Hsieh Ming-Hong, Wu Yi-Liang, Tsao Thomas Chang-Yao, Huang Yi-Wen, Lin Jian-Cheng, Lee Chia-Yi, Hsieh Ming-Ju, Yang Shun-
| Using combined CT-clinical radiomics models to identify epidermal growth factor receptor mutation subtypes in lung adenocarcinoma.
Frontiers in oncology 2022 12 846589.
Huo Ji-Wen, Luo Tian-You, Diao Le, Lv Fa-Jin, Chen Wei-Dao, Yu Rui-Ze, Li